Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2011

Apr 22, 2011

30071_dirs_2011-04-22_f691ac67-26ed-498b-94ae-2845ee7ee8af.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2011-04-20

Reporting Person: Sandercock Brett (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-04-20 ResMed Common Stock S 10000 $33.00 Disposed 50111.86 Direct

Footnotes

F1: Trade was executed pursuant to a 10b5-1 trading plan.